Target
Glucagon receptor
Ligand
BDBM50007288
Substrate
n/a
Meas. Tech.
ChEMBL_1338728 (CHEMBL3242199)
IC50
65±n/a nM
Citation
 DeMong, DDai, XHwa, JMiller, MLin, SIKang, LStamford, AGreenlee, WYu, WWong, MLavey, BKozlowski, JZhou, GYang, DYPatel, BSoriano, AZhai, YSondey, CZhang, HLachowicz, JGrotz, DCox, KMorrison, RAndreani, TCao, YLiang, MMeng, TMcNamara, PWong, JBradley, PFeng, KIBelani, JChen, PDai, PGauuan, JLin, PZhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article
Target
Name:
Glucagon receptor
Synonyms:
GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR)
Type:
Enzyme
Mol. Mass.:
54026.92
Organism:
Homo sapiens (Human)
Description:
P47871
Residue:
477
Sequence:
MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF
  
Inhibitor
Name:
BDBM50007288
Synonyms:
CHEMBL3238243
Type:
Small organic molecule
Emp. Form.:
C35H47Cl2N7O2
Mol. Mass.:
668.699
SMILES:
CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCCC1=NNNN1 |r,wU:6.5,15.19,wD:12.13,c:10,t:45,(52.53,-14.67,;52.51,-13.13,;51.17,-12.38,;51.17,-13.89,;53.84,-12.35,;53.82,-10.81,;55.14,-10.02,;55.09,-8.49,;56.3,-7.54,;57.78,-7.95,;55.77,-6.09,;54.22,-6.15,;53.81,-7.63,;52.62,-6.64,;51.17,-7.17,;50.91,-8.69,;52.1,-9.68,;53.55,-9.14,;49.57,-9.45,;48.25,-8.67,;49.56,-10.99,;48.23,-10.21,;56.54,-4.76,;55.78,-3.42,;56.56,-2.09,;55.79,-.76,;58.1,-2.1,;58.86,-3.44,;60.4,-3.45,;58.09,-4.77,;56.47,-10.81,;56.44,-12.35,;57.77,-13.14,;59.12,-12.39,;59.14,-10.85,;57.81,-10.06,;60.44,-13.18,;60.42,-14.72,;61.78,-12.42,;63.1,-13.21,;63.09,-14.75,;64.41,-15.53,;64.56,-17.06,;66.06,-17.4,;66.85,-16.08,;65.83,-14.92,)|
Structure:
Search PDB for entries with ligand similarity: